{"id":62632,"date":"2026-02-11T16:05:59","date_gmt":"2026-02-11T15:05:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/merz-aesthetics-celebrates-15-years-of-xeomin-incobotulinumtoxina-in-the-u-s-with-one-year-of-free-treatments-sweepstakes-new-campaign\/"},"modified":"2026-02-11T16:05:59","modified_gmt":"2026-02-11T15:05:59","slug":"merz-aesthetics-celebrates-15-years-of-xeomin-incobotulinumtoxina-in-the-u-s-with-one-year-of-free-treatments-sweepstakes-new-campaign","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/merz-aesthetics-celebrates-15-years-of-xeomin-incobotulinumtoxina-in-the-u-s-with-one-year-of-free-treatments-sweepstakes-new-campaign\/","title":{"rendered":"Merz Aesthetics Celebrates 15 Years of XEOMIN\u00ae (incobotulinumtoxinA) in the U.S. with One Year of Free Treatments Sweepstakes & New Campaign"},"content":{"rendered":"
\n

\nWith 43+ Million Vials Shipped Globally1<\/sup>, XEOMIN\u00ae<\/sup> continues to be a leader in the toxin industry<\/i><\/p>\n

RALEIGH, N.C.–(BUSINESS WIRE)–Merz Aesthetics, the world\u2019s largest dedicated medical aesthetics business, celebrates 15 years since its flagship brand XEOMIN\u00ae<\/sup> was first approved for aesthetic use by the U.S. Food and Drug Administration (FDA). XEOMIN\u00ae<\/sup> is a <\/i>double-purified <\/i>neurotoxin, FDA approved for the simultaneous treatment of upper facial lines \u2013 forehead lines, frown lines and crow\u2019s feet. To celebrate this 15-year U.S. milestone, 15 lucky winners will receive a year of free XEOMIN\u00ae<\/sup> treatments through Xperience+ by Merz Aesthetics U.S. patient loyalty program.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nIn addition, Merz Aesthetics is also launching a new, refreshed campaign for XEOMIN\u00ae<\/sup> in celebration of the milestone. The new multi-channel initiative\u2014spanning digital platforms to in-office touchpoints\u2014aims to empower patients to ask for XEOMIN\u00ae <\/sup>by showcasing XEOMIN\u00ae<\/sup>\u2019s natural-looking results that allow people to express themselves.<\/p>\n

\nContaining only three ingredients, XEOMIN\u00ae <\/sup>is the first and only double-purified treatment with XTRACT Technology\u00ae<\/sup>, clinically proven to smooth upper facial lines for natural-looking results1<\/sup>. XEOMIN\u00ae<\/sup> has a 96% patient satisfaction rate2,3 <\/sup>and a clinically proven track record of delivering safe, effective, and consistent results.2,4,5<\/sup><\/p>\n

\n\u201cSince its debut, XEOMIN\u00ae<\/sup><\/i> has been a trusted choice for patients and providers seeking effective, natural-looking results,\u201d said Patrick Urban, President, North America, Merz Aesthetics. \u201cCelebrating 15 years is more than a milestone\u2014it\u2019s a testament to our unwavering commitment to proven performance and advancing aesthetic care.\u201d<\/p>\n

\nWith XEOMIN\u00ae<\/sup>, no patients in pivotal clinical studies developed treatment resistance due to neutralizing antibodies. In fact, unnecessary proteins found in some other toxin formulations on the U.S. market may cause an immune response which can lead to a decreased effect and failure of treatment.6<\/sup> In a recent survey, just over 1 in 3 toxin users reported to have experienced decreased, or lessening effects, of toxin treatments.7 <\/sup>XEOMIN\u00ae<\/sup>\u2019s formulation minimizes this risk and offers a consistent experience, treatment after treatment.<\/p>\n

\n\u201cLeveraging our proprietary XTRACT Technology\u00ae<\/sup> manufacturing process, we have established ourselves as a pioneer in neurotoxins, delivering outcomes and efficacy that both patients and providers expect,\u201d said Dr. Samantha Kerr, Chief Scientific Officer, Merz Aesthetics. \u201cWe\u2019re committed to driving continued innovation for years to come.\u201d<\/p>\n

\nTo celebrate this U.S. milestone, XEOMIN\u00ae<\/sup> is giving 15 lucky U.S. patients the opportunity to win a free year of XEOMIN\u00ae<\/sup> treatments through Xperience+ by Merz Aesthetics with a participating Xperience+ provider. From February 11 to March 11, 2026, patients are invited to enter HERE<\/a> and create an account or login to Xperience+ at xperiencemerz.com<\/a>. No purchase necessary. Full terms and conditions are included in the entry form.<\/p>\n

\nTo learn more about XEOMIN\u00ae<\/sup> and locate a local provider, visit XeominAesthetic.com<\/a> to access the Find a Provider<\/a> tool. Or sign up for Xperience+ at xperiencemerz.com<\/a> to receive instant and future rewards on XEOMIN\u00ae <\/sup>and additional Merz Aesthetics <\/sup><\/b>treatments.<\/p>\n

\nKeep up with XEOMIN\u00ae<\/sup> on Instagram @XeominAesthetic<\/a>.<\/p>\n

\nReferences<\/p>\n

    \n
  1. \nMerz Data on File 2025; Combined Merz Aesthetics and Merz Therapeutics.<\/li>\n
  2. \nKane MA, et al. Dermatol Surg. 2015;41(11):1319.<\/li>\n
  3. \nPrager W. et al. Clin Cosmet Investig Dermatol. 2012;5: 53-58.<\/li>\n
  4. \nFischer T, et al. JDD. 2020;19(5):461-469.<\/li>\n
  5. \nRzany B, et al. Dermatol Surg. 2013 Jan;39(1):95-103.<\/li>\n
  6. \nHefter et al. Ther Adv Neurol Disord. 2019 Dec 16;12:1756286419892078.<\/li>\n
  7. \nMerz Data on File 2023.<\/li>\n<\/ol>\n

    \nAbout Merz Aesthetics<\/i><\/b><\/p>\n

    \nMerz Aesthetics is a medical aesthetics business with a long history of empowering health care professionals, patients and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves \u2014 however they define it. Clinically proven, its product portfolio includes injectables, devices and skin care treatments designed to meet each patient\u2019s needs with high standards of safety and efficacy. Being family owned for more than 115 years, Merz Aesthetics is known for building unique connections with customers who feel like family. Merz Aesthetics\u00ae<\/sup>\u2019 global headquarters is in Raleigh, N.C., with a commercial presence in 90 countries worldwide. It is also a part of Merz Group, which was founded in 1908 and is based in Frankfurt, Germany. Learn more at <\/i>us.merzaesthetics.com<\/i><\/a>.<\/i><\/p>\n

    \nAbout XEOMIN<\/i>\u00ae<\/sup><\/i> <\/i><\/sup>(incobotulinumtoxinA)<\/i><\/b><\/p>\n

    \nXEOMIN\u00ae<\/sup> (incobotulinumtoxinA) is a botulinum toxin type A approved by the U.S. Food and Drug Administration (FDA) for the simultaneous treatment of upper facial lines \u2013 forehead lines, frown lines and crow\u2019s feet. XEOMIN\u00ae<\/sup> is indicated to temporarily improve the look of moderate to severe upper facial lines. For more information, including Full Prescribing Information and Medication Guide, please visit <\/i>www.xeominaesthetic.com<\/i><\/a>. See below for Important Consumer Safety Information.<\/i><\/p>\n

    \nHead-to-head studies evaluating the relative risk of immunogenicity due to the presence or absence of complexing\/unnecessary proteins have not been performed.<\/p>\n

    \nXEOMIN\u00ae<\/sup> (incobotulinumtoxinA) IMPORTANT CONSUMER SAFETY INFORMATION<\/b><\/p>\n

    \nRead the Medication Guide before you start receiving XEOMIN (Zeo-min) and each time XEOMIN is given to you as there may be new information. The risk information provided here is not comprehensive.<\/p>\n

    \nTo learn more:<\/p>\n